Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:34 PM
Ignite Modification Date:
2025-12-24 @ 7:34 PM
NCT ID:
NCT05560503
Eligibility Criteria:
Inclusion Criteria:
* meet the diagnostic standard presented in Asian-Pacific clinical practice guidelines on the management of hepatitis B.
* HBsAg-positive for over 6 months.
* aged 18-65 years old.
* no gender limitation.
Exclusion Criteria:
* co-infection with other types of hepatitis viruses, including types A, C, D, and E.
* co-infection with human immunodeficiency virus (HIV).
* autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), inherited metabolic liver disease, drug-induced liver injury (DILI), alcoholic liver disease, and hepatocellular carcinoma (HCC).
* with other malignant tumor and other major systemic diseases.
* incomplete clinical data.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT05560503
Study Brief:
Protocol Section:
NCT05560503